Whether increased levels or activity of PAI-1 are a cause or consequence of COVID-19 exacerbation remains unclear; nevertheless inhibiting PAI-1 function is a potential strategy for preventing COVID-19 disease progression. This evidence concerns the gene SERPINE1 and COVID-19.